Financials

News Discussions Technicals Seasonals

CEL fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Celadon Pharmaceuticals Plc. engages in the research, cultivation, manufacturing and supply of cannabinoid-based medicines. Its focuses on improving quality of life for chronic pain sufferers and exploring the potential of cannabinoid-based medicines for other conditions such as autism. The company was founded in 2018 and is headquartered in London, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

CEL has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company